Certara (NASDAQ:CERT) Stock Price Expected to Rise, Barclays Analyst Says

Key Points

• Barclays raised Certara’s price target to $7.50 from $6.50 while maintaining an “equal weight” rating, implying roughly 3.85% downside from the prior close.
• Analyst sentiment remains cautious: Certara has an average “Hold” rating and a consensus price target of $8.95, with several firms recently lowering their targets.
• Certara missed quarterly expectations, reporting $0.08 in earnings per share versus $0.09 expected and revenue of $93.27 million versus $98.09 million estimated; revenue declined 10.8% year over year.

Certara (NASDAQ:CERT - Get Free Report) had its price target lifted by Barclays from $6.50 to $7.50 in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has an "equal weight" rating on the stock. Barclays's price target indicates a potential downside of 3.85% from the company's previous close.

A number of other equities research analysts have also commented on CERT. Morgan Stanley reduced their price target on Certara from $11.00 to $10.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 12th. BMO Capital Markets lowered their price objective on Certara from $7.00 to $6.00 and set a "market perform" rating for the company in a research report on Tuesday, May 12th. Craig Hallum cut their price objective on Certara from $10.00 to $8.00 and set a "hold" rating on the stock in a research note on Tuesday, May 12th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Certara in a report on Friday, May 29th. Finally, Robert W. Baird decreased their target price on shares of Certara from $7.00 to $6.00 and set a "neutral" rating for the company in a research report on Tuesday, May 12th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Certara has an average rating of "Hold" and an average target price of $8.95.

Certara Price Performance

Shares of NASDAQ:CERT opened at $7.80 on Wednesday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. Certara has a 52 week low of $4.45 and a 52 week high of $13.88. The firm has a market cap of $1.21 billion, a PE ratio of -78.00 and a beta of 1.44. The firm's fifty day moving average is $6.41 and its 200-day moving average is $6.56.

Certara (NASDAQ:CERT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). The company had revenue of $93.27 million during the quarter, compared to analyst estimates of $98.09 million. Certara had a negative net margin of 3.60% and a positive return on equity of 3.52%. The business's revenue for the quarter was down 10.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.07 earnings per share. Sell-side analysts predict that Certara will post 0.24 earnings per share for the current year.

Institutional Trading of Certara

A number of large investors have recently bought and sold shares of the business. Osaic Holdings Inc. lifted its stake in shares of Certara by 50.7% in the 2nd quarter. Osaic Holdings Inc. now owns 3,491 shares of the company's stock valued at $41,000 after purchasing an additional 1,175 shares during the period. Corient Private Wealth LLC grew its stake in Certara by 11.7% during the second quarter. Corient Private Wealth LLC now owns 12,362 shares of the company's stock worth $144,000 after purchasing an additional 1,295 shares during the period. Central Pacific Bank Trust Division grew its stake in Certara by 8.7% during the second quarter. Central Pacific Bank Trust Division now owns 19,460 shares of the company's stock worth $127,000 after purchasing an additional 1,558 shares during the period. Treasurer of the State of North Carolina increased its holdings in Certara by 2.9% in the second quarter. Treasurer of the State of North Carolina now owns 56,628 shares of the company's stock worth $663,000 after purchasing an additional 1,597 shares in the last quarter. Finally, Nicolet Advisory Services LLC increased its holdings in Certara by 7.4% in the third quarter. Nicolet Advisory Services LLC now owns 30,608 shares of the company's stock worth $396,000 after purchasing an additional 2,100 shares in the last quarter. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Certara Company Profile

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company's platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company's offerings are divided into software tools and consulting services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source